Kuros Biosciences AG (KURN.XSWX) Financials
All currency values in CHF millions unless otherwise noted
Scroll
| Income Statement | DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | CHF 146 | CHF 85 | CHF 34 | CHF 18 | CHF 14 |
| Cost of Revenue | CHF 17 | CHF 15 | CHF 10 | CHF 7 | CHF 4 |
| Gross Profit | CHF 129 | CHF 70 | CHF 24 | CHF 11 | CHF 10 |
| Total Operating Expenses | CHF 120 | CHF 76 | CHF 34 | CHF 24 | CHF 19 |
| Operating Income | CHF 9 | -CHF 6 | -CHF 10 | -CHF 13 | -CHF 9 |
| Non-Operating | |||||
| Net Interest Expense | -CHF 0 | -CHF 0 | -CHF 0 | -CHF 0 | -CHF 1 |
| Income Tax Expense | CHF 3 | CHF 0 | CHF 0 | -CHF 1 | -CHF 2 |
| Net Income | |||||
| Net Income | CHF 3 | -CHF 5 | -CHF 10 | -CHF 15 | -CHF 8 |
| Per Share Data | |||||
| Revenue Per Share | CHF 3.93 | CHF 2.29 | CHF 0.92 | CHF 0.53 | CHF 0.42 |
| EPS (Basic) | CHF 0.07 | -CHF 0.13 | -CHF 0.38 | -CHF 0.43 | -CHF 0.23 |
| EPS (Diluted) | CHF 0.07 | -CHF 0.13 | -CHF 0.38 | -CHF 0.43 | -CHF 0.23 |
| Shares Outstanding | 37.2M | 37.2M | 36.6M | 33.9M | 32.8M |
Kuros Biosciences (KURN.XSWX) financials: revenue, profit and margins
Kuros Biosciences (KURN.XSWX) generated about CHF 146 million in revenue and CHF 3 million in net income (a 1.7% net margin) over the trailing twelve months, growing at roughly 80.3% a year. Figures are from company filings; this is analysis, not investment advice.
Frequently asked
What is Kuros Biosciences's (KURN.XSWX) revenue?+
Kuros Biosciences generated about CHF 146 million in revenue over the trailing twelve months. Revenue has grown at roughly 80.3% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Is Kuros Biosciences profitable?+
Yes, Kuros Biosciences reported about CHF 3 million in net income over the trailing twelve months, a net profit margin of roughly 1.7%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
What are Kuros Biosciences's profit margins?+
Kuros Biosciences runs a gross margin of about 88.6%, an operating margin of about 6.1%, a net margin of about 1.7%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
How fast is Kuros Biosciences growing?+
Kuros Biosciences's revenue has compounded at roughly 80.3% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside KURN.XSWX's margins and free cash flow. This is analysis from company filings, not investment advice.
Related stocks: Medical Devices
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.